RVTYRevvity
About Revvity
Revvity (NYSE:RVTY) is a life sciences company that promotes scientific advancements through a comprehensive suite of products, services, and solutions. Operating in both diagnostics and life sciences, they equip researchers and clinicians with the tools and expertise needed for breakthroughs in areas like disease research, drug discovery, and improved diagnoses. Emphasizing innovation, Revvity strives to be a reliable partner across various scientific fields, contributing to a healthier future. This focus on diverse solutions and a growing market cap position Revvity as a key player in the global scientific landscape.
What is RVTY known for?
Snapshot
Public US
Ownership
1937
Year founded
2807
Employees
Massachusetts, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Products and/or services of Revvity
- Instruments: Revvity provides advanced scientific instruments like mass spectrometers, sequencers, and microscopes used in life sciences research, drug discovery, and diagnostics. These instruments enable researchers to analyze complex biological samples, identify molecules, and understand cellular processes.
- Reagents: Revvity offers a diverse portfolio of reagents, including antibodies, enzymes, and buffers, which are essential components for conducting various scientific experiments and diagnostic assays. These high-quality reagents ensure accurate and reliable results across different research and clinical applications.
- Software: Revvity leverages software solutions to empower researchers and clinicians. This includes software for data analysis, instrument control, and scientific modeling. These tools help researchers interpret complex data sets, visualize results, and design experiments efficiently. In the diagnostics segment, software might streamline patient data management and reporting.
- Assay Platforms: Revvity provides pre-designed assay platforms, which are standardized tests used to detect specific molecules or analyze biological processes. These platforms offer efficient and cost-effective solutions for applications ranging from disease diagnosis to drug screening.
- Contract Research Services: Revvity offers contract research services to support research institutions and pharmaceutical companies. These services can include experimental design, sample analysis, and data interpretation. Partnering with Revvity allows access to their expertise and advanced technologies, accelerating research and development efforts.
- Licensing: Revvity fosters innovation by offering licensing opportunities for their intellectual property. This allows other companies to leverage their expertise and technologies for developing novel diagnostic tests, therapeutic products, or research tools.
Revvity executive team
- Dr. Prahlad R. Singh Ph.D.CEO, President & Director
- Mr. Maxwell KrakowiakSenior VP & CFO
- Mr. Tajinder S. VohraSenior Vice President of Global Operations
- Mr. Joel S. GoldbergSenior VP of Administration, General Counsel & Secretary
- Ms. Miriame VictorSenior VP & Chief Commercial Officer
- Ms. Anita GonzalesChief Accounting Officer, VP & Controller
- Mr. Bryan A. KippSenior VP of Technology & Licensing
- Ms. Madhuri Hegde FACMG, Ph.D.Senior VP & Chief Scientific Officer
- Mr. Stephen Barr WilloughbySenior VP of Investor Relations & Head of ESG
- Ms. Magali FourSenior VP and Chief People & Culture Officer